Pluripotent stem cell for modeling neurological diseases
Jasmine Sum-Yee Yung1, Paul Kwong-Hang Tam, Elly Sau-Wai Ngan
1Department of Surgery, Development and Growth, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong.
Experimental Cell Research
|November 20, 2012
Summary
Human pluripotent stem cells, including embryonic (ESC) and induced (iPSC) stem cells, offer a renewable source for studying neurological diseases. Patient-derived stem cells enable disease modeling and drug discovery for neurological disorders.
Area of Science:
- Stem cell biology
- Neuroscience
- Genomics
Background:
- Human pluripotent stem cells (hPSCs), encompassing embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), provide a valuable tool for biological research.
- These cells can be used to study early human development and the progression of various diseases.
- Patient-specific ESCs/iPSCs allow for disease modeling using the patient's own genetic material.
Purpose of the Study:
- To review recent advancements in utilizing patient-derived ESCs/iPSCs for modeling neurological diseases.
- To discuss the challenges and limitations associated with current stem cell-based disease models.
- To explore the future potential of these models in understanding neurological disorders.
Main Methods:
- Generation of specific neuronal subtypes from patient-derived ESCs and iPSCs.
- Application of these neuronal models for studying disease mechanisms.
- Utilizing patient-specific stem cell models for drug discovery.
Main Results:
- Patient-derived ESCs/iPSCs have emerged as a key resource for neurological disease research.
- These models facilitate the study of disease etiology and progression at the cellular level.
- The use of patient-specific stem cells aids in identifying potential therapeutic targets and drug candidates.
Conclusions:
- Stem cell-based disease modeling holds significant promise for advancing our understanding of neurological disorders.
- Addressing current challenges is crucial for maximizing the potential of these models.
- Future applications include personalized medicine approaches and the development of novel treatments for neurological conditions.
More Related Videos
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.